![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
Reset all filters
01 3Eli Lilly
02 2QILU PHARMACEUTICAL CO., LTD.
Reset all filters
01 2TABLET
02 3TABLET;ORAL
Reset all filters
01 1DISCN
02 2RX
03 2Blank
Reset all filters
01 2LASMIDITAN
02 3REYVOW
Reset all filters
01 5USA
Regulatory Info : RX
Registration Country : USA
Brand Name : REYVOW
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 50MG BASE
Packaging :
Approval Date : 2020-01-31
Application Number : 211280
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : REYVOW
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 100MG BASE
Packaging :
Approval Date : 2020-01-31
Application Number : 211280
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : REYVOW
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 200MG BASE
Packaging :
Approval Date : 2020-12-18
Application Number : 211280
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : LASMIDITAN
Dosage Form : TABLET
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number : 219350
Regulatory Info :
Registration Country : USA
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : USA
Brand Name : LASMIDITAN
Dosage Form : TABLET
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number : 219350
Regulatory Info :
Registration Country : USA
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
LOOKING FOR A SUPPLIER?